EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Purpura fulminans: MRSA sepsis compounded by diclofenac

Mahym Mansoor, Wajieha Saeed, Faria Altaf, Ijaz Hussain, Farwa Nasir Khan

Journal of Pakistan Association of Dermatologists · 12.10.2023 · 33 (4) · 1780-1782

DOI: 10.66344/jpad.v33i4.2589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 12.10.2023. Verfasst von Mahym Mansoor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpura fulminans is a rare, albeit a life-threatening emergency which has been reportedly triggered by infections, congenital disorders of protein C or S deficiencies, as well as drugs. Here we report a case of a previously healthy 17 year old male who developed purpura fulminans after fever, sore throat and then getting injection diclofenac. Blood cultures grew Staph. aureus. This case is the first to report two causative etiologies in a single patient.

Zitieren

APA

Mansoor, M., Saeed, W., Altaf, F., Hussain, I., & Khan, F. N. (2023). Purpura fulminans: MRSA sepsis compounded by diclofenac. Journal of Pakistan Association of Dermatologists, 33(4), 1780-1782. https://doi.org/10.66344/jpad.v33i4.2589

Vancouver

Mansoor M, Saeed W, Altaf F, Hussain I, Khan FN. Purpura fulminans: MRSA sepsis compounded by diclofenac. Journal of Pakistan Association of Dermatologists. 2023;33(4):1780-1782. doi:10.66344/jpad.v33i4.2589

BibTeX
@article{Mansoor2023,
  author = {Mansoor, Mahym and Saeed, Wajieha and Altaf, Faria and Hussain, Ijaz and Khan, Farwa Nasir},
  title = {Purpura fulminans: MRSA sepsis compounded by diclofenac},
  journal = {Journal of Pakistan Association of Dermatologists},
  year = {2023},
  volume = {33},
  number = {4},
  pages = {1780--1782},
  doi = {10.66344/jpad.v33i4.2589}
}
Kostenlos starten →